{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:39:04Z","timestamp":1790797144652,"version":"4.1.0"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Lu 634\/8-1"],"award-info":[{"award-number":["Lu 634\/8-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Lu 634\/9-1"],"award-info":[{"award-number":["Lu 634\/9-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Re 1631\/15-1"],"award-info":[{"award-number":["Re 1631\/15-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01200","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T10:53:47Z","timestamp":1559127227000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["Glucocorticoid Therapy of Multiple Sclerosis Patients Induces Anti-inflammatory Polarization and Increased Chemotaxis of Monocytes"],"prefix":"10.3389","volume":"10","author":[{"given":"Henrike J.","family":"Fischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias L. K.","family":"Finck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah L.","family":"Pellkofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger M.","family":"Reichardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"L\u00fchder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1055\/s-0036-1579739","article-title":"Immunology of multiple sclerosis","volume":"36","author":"Sospedra","year":"2016","journal-title":"Semin Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1136\/jnnp.50.5.511","article-title":"A double-blind controlled trial of high-dose methylprednisolone in patients with multiple-sclerosis.1. Clinical effects","volume":"50","author":"Milligan","year":"1987","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1002\/art.20583","article-title":"Glucocorticoids in the treatment of rheumatic diseases - an update on the mechanisms of action","volume":"50","author":"Buttgereit","year":"2004","journal-title":"Arthritis Rheum."},{"key":"B4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.autrev.2010.11.009","article-title":"The kaleidoscope of glucorticoid effects on immune system","volume":"10","author":"Zen","year":"2011","journal-title":"Autoimmun Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1084\/jem.20180595","article-title":"Immune regulation by glucocorticoids can be linked to cell type-dependent transcriptional responses","volume":"216","author":"Franco","year":"2019","journal-title":"J Exp Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1191\/1352458505ms1190oa","article-title":"The mechanism of action of methylprednisolone in the treatment of multiple sclerosis","volume":"11","author":"Sloka","year":"2005","journal-title":"Mult Scler."},{"key":"B7","doi-asserted-by":"publisher","first-page":"8434","DOI":"10.4049\/jimmunol.180.12.8434","article-title":"Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis","volume":"180","author":"W\u00fcst","year":"","journal-title":"Immunol J. ("},{"key":"B8","doi-asserted-by":"publisher","first-page":"e8202","DOI":"10.1371\/journal.pone.0008202","article-title":"Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis","volume":"4","author":"W\u00fcst","year":"2009","journal-title":"PLoS ONE."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.4049\/jimmunol.1101604","article-title":"Liposomal encapsulation of glucocorticoids alters their mode of action in the treatment of experimental autoimmune encephalomyelitis","volume":"187","author":"Schweingruber","year":"","journal-title":"Immunol J. ("},{"key":"B10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jconrel.2016.12.003","article-title":"Targeted delivery of glucocorticoids to macrophages in a mouse model of multiple sclerosis using inorganic-organic hybrid nanoparticles","volume":"245","author":"Montes-Cobos","year":"","journal-title":"Control Release J. ("},{"key":"B11","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00401-014-1248-4","article-title":"Chemokine-mediated redirection of T cells constitutes a critical mechanism of glucocorticoid therapy in autoimmune CNS responses","volume":"127","author":"Schweingruber","year":"2014","journal-title":"Acta Neuropathol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.bbadis.2010.07.008","article-title":"The role of antigen presenting cells in multiple sclerosis","volume":"1812","author":"Chastain","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/nn.2887","article-title":"Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool","volume":"14","author":"Ajami","year":"2011","journal-title":"Nat Neurosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1084\/jem.20132477","article-title":"Differential roles of microglia and monocytes in the inflamed central nervous system","volume":"211","author":"Yamasaki","year":"2014","journal-title":"J Exp Med."},{"key":"B15","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4049\/jimmunol.126.2.614","article-title":"The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis","volume":"126","author":"Brosnan","year":"1981","journal-title":"Immunol J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1084\/jem.172.4.1025","article-title":"Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages","volume":"172","author":"Huitinga","year":"1990","journal-title":"J Exp Med."},{"key":"B17","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.4049\/jimmunol.161.7.3767","article-title":"Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice","volume":"161","author":"Tran","year":"1998","journal-title":"Immunol J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1093\/brain\/awp144","article-title":"CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system","volume":"132","author":"Mildner","year":"2009","journal-title":"Brain"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.4049\/jimmunol.1501960","article-title":"Pivotal role for CD16+ monocytes in immune surveillance of the central nervous system","volume":"196","author":"Waschbisch","year":"2016","journal-title":"Immunol J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fimmu.2013.00023","article-title":"Toward a refined definition of monocyte subsets","volume":"4","author":"Ziegler-Heitbrock","year":"2013","journal-title":"Front Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/fimmu.2014.00614","article-title":"Molecular mechanisms that influence the macrophage m1-m2 polarization balance","volume":"5","author":"Wang","year":"2014","journal-title":"Front Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"7144","DOI":"10.4049\/jimmunol.172.11.7144","article-title":"Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis","volume":"172","author":"Kim","year":"2004","journal-title":"J Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nm1620","article-title":"Type II monocytes modulate T cell-mediated central nervous system autoimmune disease","volume":"13","author":"Weber","year":"2007","journal-title":"Nat Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1002\/eji.201141947","article-title":"IL-33 attenuates EAE by suppressing IL-17 and IFN-gamma production and inducing alternatively activated macrophages","volume":"42","author":"Jiang","year":"2012","journal-title":"Eur Immunol J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1177\/1352458510379243","article-title":"Altered M1\/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration","volume":"17","author":"Mikita","year":"2011","journal-title":"Mult Scler."},{"key":"B26","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1182\/blood.V82.10.3170.3170","article-title":"The novel subset of CD14+\/CD16+ blood monocytes is expanded in sepsis patients","volume":"82","author":"Fingerle","year":"1993","journal-title":"Blood."},{"key":"B27","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/rheumatology\/keh112","article-title":"Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis","volume":"43","author":"Hepburn","year":"2004","journal-title":"Rheumatology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1002\/art.10545","article-title":"CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis","volume":"46","author":"Kawanaka","year":"2002","journal-title":"Arthritis Rheum."},{"key":"B29","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1346-8138.2003.tb00424.x","article-title":"Circulating CD14+ CD16+ monocytes are expanded in sarcoidosis patients","volume":"30","author":"Okamoto","year":"","journal-title":"Dermatol J. ("},{"key":"B30","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/art.33418","article-title":"The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population","volume":"64","author":"Rossol","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.clim.2016.10.013","article-title":"Phenotypic changes of peripheral blood mononuclear cells upon corticosteroid treatment in idiopathic intermediate uveitis","volume":"173","author":"Walscheid","year":"2016","journal-title":"Clin Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0165-5728(00)00396-9","article-title":"Monocytes in multiple sclerosis: phenotype and cytokine profile","volume":"112","author":"Kouwenhoven","year":"2001","journal-title":"Neuroimmunol J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/icb.2014.15","article-title":"Expansion and preferential activation of the CD14(+)CD16(+) monocyte subset during multiple sclerosis","volume":"92","author":"Chuluundorj","year":"2014","journal-title":"Immunol Cell Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/acn3.270","article-title":"Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis","volume":"3","author":"Michell-Robinson","year":"2016","journal-title":"Ann Clin Transl Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1212\/NXI.0000000000000157","article-title":"Myeloid cells as target of fingolimod action in multiple sclerosis","volume":"2","author":"Di","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1182\/blood-2006-02-001115","article-title":"Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes","volume":"109","author":"Ehrchen","year":"2007","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.4049\/jimmunol.1300891","article-title":"Immune suppression via glucocorticoid-stimulated monocytes: a novel mechanism to cope with inflammation","volume":"193","author":"Varga","year":"2014","journal-title":"Immunol J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.4049\/jimmunol.1402409","article-title":"CD14++CD16+ monocytes are enriched by glucocorticoid treatment and are functionally attenuated in driving effector T cell responses","volume":"194","author":"Liu","year":"2015","journal-title":"Immunol J."},{"key":"B39","first-page":"2295s","article-title":"Regulation of glucocorticoid receptor protein and mRNA levels","volume":"49","author":"Vedeckis","year":"1989","journal-title":"Cancer Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/0039-128X(91)90124-E","article-title":"Autoregulation of glucocorticoid receptor gene expression","volume":"56","author":"Burnstein","year":"1991","journal-title":"Steroids."},{"key":"B41","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bbadis.2010.07.019","article-title":"The blood-brain barrier, chemokines and multiple sclerosis","volume":"1812","author":"Holman","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"B42","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.semarthrit.2008.11.002","article-title":"The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: a reappraisal","volume":"39","author":"Katsiari","year":"2010","journal-title":"Semin Arthritis Rheum."},{"key":"B43","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00281-015-0519-z","article-title":"Differential roles of resident microglia and infiltrating monocytes in murine CNS autoimmunity","volume":"37","author":"Shemer","year":"2015","journal-title":"Semin Immunopathol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1371\/journal.pmed.0040124","article-title":"TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis","volume":"4","author":"Takahashi","year":"2007","journal-title":"PLoS Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1517\/14728222.7.1.35","article-title":"Targeting monocyte chemoattractant protein-1 signalling in disease","volume":"7","author":"Dawson","year":"2003","journal-title":"Exp Opn Ther Targets."},{"key":"B46","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1042\/BJ20071493","article-title":"Chemokines and cancer: migration, intracellular signalling and intracellular communication in the microenvironment","volume":"409","author":"O'Hayre","year":"2008","journal-title":"Biochem J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/jcp.22383","article-title":"Involvement of \u00df1-integrin via pip complex and FAK\/paxillin in dexamethason-induced human mesenchymal stem cell migration","volume":"226","author":"Yun","year":"2011","journal-title":"J Cell Physiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.4049\/jimmunol.1201520","article-title":"Glucocorticoids induce effector T cell depolarization via ERM proteins, thereby impeding migration and APC conjugation","volume":"190","author":"M\u00fcller","year":"2013","journal-title":"Immunol J."},{"key":"B49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1742-2094-11-23","article-title":"Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation","volume":"11","author":"Vogel","year":"2014","journal-title":"Neuroinflammation J."},{"key":"B50","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S0165-5728(01)00487-8","article-title":"Interferon beta-1b modulates MCP-1 expression and production in relapsing-remitting multiple sclerosis","volume":"123","author":"Iarlori","year":"2002","journal-title":"Neuroimmunol J."},{"key":"B51","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1615\/CritRevImmunol.v29.i3.50","article-title":"Traditional concepts and future avenues of glucocorticoid action in experimental autoimmune encephalomyelitis and multiple sclerosis therapy","volume":"29","author":"L\u00fchder","year":"2009","journal-title":"Crit Rev Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/jlb.67.6.801","article-title":"Dexamethasone promotes phagocytosis and bacterial killing by human monocytes\/macrophages in vitro","volume":"67","author":"van der Goes","year":"2000","journal-title":"J Leukoc Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.4049\/jimmunol.0713732","article-title":"M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro","volume":"182","author":"Leidi","year":"2009","journal-title":"Immunol J."},{"key":"B54","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1161\/CIRCRESAHA.110.233775","article-title":"Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARgamma and LXRalpha pathways","volume":"108","author":"Chinetti-Gbaguidi","year":"2011","journal-title":"Circ Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jneuroim.2006.03.024","article-title":"High dose of intravenously given glucocorticosteroids decrease IL-8 production by monocytes in multiple sclerosis patients treated during relapse","volume":"176","author":"Mirowska-Guzel","year":"2006","journal-title":"Neuroimmunol J."},{"key":"B56","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1096\/fj.07-9002com","article-title":"Glucocorticoids regulate innate immunity in a model of multiple sclerosis: reciprocal interactions between the A1 adenosine receptor and beta-arrestin-1 in monocytoid cells","volume":"22","author":"Tsutsui","year":"2008","journal-title":"Faseb J"},{"key":"B57","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.4049\/jimmunol.157.10.4634","article-title":"Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264","volume":"157","author":"Hasko","year":"1996","journal-title":"Immunol J."},{"key":"B58","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1189\/jlb.1107768","article-title":"Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells","volume":"84","author":"Varga","year":"2008","journal-title":"J Leukoc Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1477-7827-6-17","article-title":"The glycoprotein-hormones activin A and inhibin A interfere with dendritic cell maturation","volume":"6","author":"Segerer","year":"2008","journal-title":"Reprod Biol Endocrinol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1038\/s41598-019-39395-9","article-title":"Extensive epigenomic integration of the glucocorticoid response in primary human monocytes and in vitro derived macrophages","volume":"9","author":"Wang","year":"2019","journal-title":"Sci Rep."},{"key":"B61","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3389\/fimmu.2015.00463","article-title":"Pathologic and protective roles for microglial subsets and bone marrow- and blood-derived myeloid cells in central nervous system inflammation","volume":"6","author":"Wlodarczyk","year":"2015","journal-title":"Front Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00401-015-1418-z","article-title":"Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis","volume":"130","author":"Khorooshi","year":"2015","journal-title":"Acta Neuropathol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01200\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T00:15:25Z","timestamp":1694909725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01200\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,29]]},"references-count":62,"alternative-id":["10.3389\/fimmu.2019.01200"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01200","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,29]]},"article-number":"1200"}}